Atlas FDA

RxSight Light Adjustable Lens and Light Delivery Device

FDA premarket approval P160055/S015 · decided 2021-04-20

Approval details

PMA number
P160055
Supplement
S015
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
RxSight Light Adjustable Lens and Light Delivery Device
Generic name
Light adjustable lens (LAL) and light delivery device (LDD)
Applicant
Rxsight, Inc.
Date received
2020-10-22
Decision date
2021-04-20
Days to decision
180 days
Decision code
APPR
Product code
PZK
Advisory committee
Ophthalmic
Expedited review
No
Location
Aliso Viejo, CA
Statement
Approval for (1) a simplified fixed output beam aperture in place of the current motorized aperture, (2) update to LDD lock-in treatment profile to reduce ocular exposure, (3) update to the Windows 10 operating system, (4) extension of dioptric power range to include +4.0 to +9.0 diopters, (5) introduce an additional UV-A absorber to the anterior portion of the LAL, and (6) updates to manufacturing work instructions, LDD Graphical User Interface (GUI), and user labeling to reflect all modificati

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
RxSight® Insertion Device (K261174)Rxsight, Inc.2026-06-10
RxSight® Insertion Device (63002) (K231838)Rxsight, Inc.2023-08-15
RxSight Insertion Device (K231466)Rxsight, Inc.2023-06-12
RxSight Contact Lens (K201909)Rxsight, Inc.2020-09-10
RxSight Insertion Device (K192926)Rxsight, Inc.2020-01-17
RxSight Insertion Device (K181401)Rxsight, Inc.2018-07-26